RIGL, PPWE.PK, AFFX, PWRM.OB, HEAT, - CRWESelect.com Stock Report! Rigel Pharmaceuticals, Proper Power and Energy, Affymetrix

Rigel Pharmaceuticals, Inc (NASDAQ:RIGL) reported financial results for the fourth quarter and year ended December 31, 2010. For the fourth quarter of 2010, Rigel reported a net loss of $17.2 million, or $0.33 per share, compared to a net loss of $25.1 million, or $0.48 per share, in the fourth quarter of 2009.